Success Metrics

Clinical Success Rate
66.7%

Based on 4 completed trials

Completion Rate
67%(4/6)
Active Trials
0(0%)
Results Posted
75%(3 trials)
Terminated
2(25%)

Phase Distribution

Ph phase_4
1
13%
Ph not_applicable
6
75%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution7 total trials
Phase 4Post-market surveillance
1(14.3%)
N/ANon-phased studies
6(85.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

57.1%

4 of 7 finished

Non-Completion Rate

42.9%

3 ended early

Currently Active

0

trials recruiting

Total Trials

8

all time

Status Distribution
Completed(4)
Terminated(3)
Other(1)

Detailed Status

Completed4
Terminated2
Withdrawn1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
0
Success Rate
66.7%
Most Advanced
Phase 4

Trials by Phase

Phase 41 (14.3%)
N/A6 (85.7%)

Trials by Status

withdrawn113%
terminated225%
completed450%
unknown113%

Recent Activity

0 active trials
Showing 5 of 8
completednot_applicable

EndoBarrier in Obstructive Sleep Apnoea Study

NCT06376305
completednot_applicable

EndoBarrier in Obese Subjects With Type 2 Diabetes Mellitus

NCT02769728
terminatednot_applicable

ENDOBARRIER® and Conventional Therapy in the Management of Metabolic Syndrome in Obese Patients

NCT02297555
terminatednot_applicable

Safety and Efficacy of EndoBarrier in Subjects With Type 2 Diabetes Who Are Obese

NCT01728116
completednot_applicable

Safety and Efficacy Study of EndoBarrier in Subjects With Type II Diabetes and Obesity

NCT00985114
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT06376305Not Applicable

EndoBarrier in Obstructive Sleep Apnoea Study

Completed
NCT02769728Not Applicable

EndoBarrier in Obese Subjects With Type 2 Diabetes Mellitus

Completed
NCT02297555Not Applicable

ENDOBARRIER® and Conventional Therapy in the Management of Metabolic Syndrome in Obese Patients

Terminated
NCT01728116Not Applicable

Safety and Efficacy of EndoBarrier in Subjects With Type 2 Diabetes Who Are Obese

Terminated
NCT00985114Not Applicable

Safety and Efficacy Study of EndoBarrier in Subjects With Type II Diabetes and Obesity

Completed
NCT02293720Not Applicable

An Open-Label Extension to Protocol 09-1, Efficacy and Safety Study of the EndoBarrier® Gastrointestinal Liner System

Withdrawn
NCT02566330

The EndoBarrier Device: A 3-year Follow up Study

Completed
NCT01718457Phase 4

Endobarrier Treatment in Obese Subjects With T2DM

Unknown

All 8 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
8